VALN

SEC filing VALN to Present at Jefferies Global Healthcare Conference, Oddo BHF Nextcap Forum, BNP Paribas SMID Cap Conference in June

1d ago

News Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine

14d ago

News Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine - Zacks Investment Research

14d ago

News Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval

14d ago

News What Analysts Are Saying About Valneva Stock

14d ago

News Valneva GAAP EPS of -€0.18, revenue of €30.9M; updates FY26 outlook

20d ago

Scanner Large down move: 37.1% (3.3x normal daily movement)

70d ago

News Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

71d ago

News Valneva inks licensing deal with Elaris for vaccine technology

76d ago

News Valneva reports FY results; gives FY26 outlook

76d ago

SEC filing VALN to Present at TD Cowen Conference, Discuss VLA15 Lyme Disease Vaccine Phase 3 Data Readout Expected H1 2026

92d ago

SEC filing VALN Updates IXCHIQ® Recommendations, Restricts Use for Individuals Over 60

109d ago

News Verizon Stock Gains on Earnings. What’s Exciting Wall Street.

123d ago

News Valneva ends chikungunya vaccine deal with India’s Serum Institute

153d ago

News VALNEVA Declaration of shares and voting rights: September 30, 2025

153d ago

News VALNEVA Declaration of shares and voting rights: November 30, 2025

153d ago